8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3,37-bis(acetyloxy)-10,14,15,17,27,43-hexahydroxy-11-[(4S,5E)-4-hydroxy-2-methylene-5,7-octadien-1-yl]-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,(1S,3S,5R,9R,10R,11R,13R,14S,15R,17S,18R,19R,23Z,25R,27S,29S,31S,33S,36S,37S,38R,41S,43S,49S)-,150624-44-5 Products Supply

Name: 8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3,37-bis(acetyloxy)-10,14,15,17,27,43-hexahydroxy-11-[(4S,5E)-4-hydroxy-2-methylene-5,7-octadien-1-yl]-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,(1S,3S,5R,9R,10R,11R,13R,14S,15R,17S,18R,19R,23Z,25R,27S,29S,31S,33S,36S,37S,38R,41S,43S,49S)-
CAS NO.: 150624-44-5
Synonyms:
8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3,37-bis(acetyloxy)-10,14,15,17,27,43-hexahydroxy-11-(4-hydroxy-2-methylene-5,7-octadienyl)-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,[1S-[1R*,3R*,5S*,9S*,10S*,11S*(4R*,5E),13S*,14R*,15S*,17R*,18S*,19S*,23Z,25S*,27R*,29R*,31R*,33R*,36R*,37R*,38S*,41R*,43R*,49R*]]-;8,12,45,46,47,48,50-Heptaoxaheptacyclo[39.3.1.11,5.19,13.115,19.125,29.129,33]pentacont-23-ene-7,35-dione,3,37-bis(acetyloxy)-10,14,15,17,27,43-hexahydroxy-11-[(4S,5E)-4-hydroxy-2-methylene-5,7-octadienyl]-31-methoxy-18,36,38,43,49-pentamethyl-39-methylene-,(1S,3S,5R,9R,10R,11R,13R,14S,15R,17S,18R,19R,23Z,25R,27S,29S,31S,33S,36S,37S,38R,41S,43S,49S)-(9CI); (+)-Altohyrtin C; (+)-Spongistatin 2; Altohyrtin C; Spongistatin 2
Molecular Structure:
Molecular Formula: C63H96 O21

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 8,12,45,46,47,48,50-Heptaoxahe; 8,12,45,46,47,48,50-Heptaoxahe; 1/C51H74N2/c1-5-9-13-17-21-49(; 1/C28H41N5O15S.Na/c1-12(2)21(2; 15-Tritetracontene-27,43-dione; 15-Tritetracontene-27,43-dione; 15-Tritetracontene-27,43-dione; 1/C33H42O7/c1-19-25-17-24-18-2; 11',29'-di-tert-butyl-5',17',2; 9,35,39,46,48,49,50,52-Octaoxa; 9,35,39,46,48,49,50,52-Octaoxa; 8,28,41,42-Tetraoxatricyclo[35; 9,35,39,46,48,49,50,52-Octaoxa; 10,32,45,46-Tetraoxatricyclo[3; 10,32,45,46-Tetraoxatricyclo[3; Propanoic acid,2-(acetyloxy)-2; 8,28,41,42-Tetraoxatricyclo[35; 10,32,45,46-Tetraoxatricyclo[3; 10,32,45,46-Tetraoxatricyclo[3; 2,4-Pyrrolidinedione,3-[(2E,4S; 1/C27H27N3O3S/c1-30-25(20-11-1; 10,32,45,46-Tetraoxatricyclo[3; 9,28-Dioxabicyclo[25.1.0]octac; Octacyclo[37.3.1.13,7.19,13.11; Somatoliberin (human pancreati; 1/C22H28O6/c1-23-17-11-21(27-5; (5E)-5-[(3aS,4R,5R,6aS)-4-[(1E; 1/C26H18O2/c1-17-16-23-21-9-5-; 1/C21H26N2O4/c1-3-14-8-9-19(25; (1S,3R,5R,6S,8R,10R,11S,13R,15;